Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 150,605 |
|
|||||
| News | - | ||||||
| Day High | 3.7497 | Low High |
|||||
| Day Low | 3.39 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aditxt Inc | ADTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 1.15% | 3.51 | 15:13:54 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.39 | 3.39 | 3.7497 | 3.51 | 3.47 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,343 | 150,605 | US$ 3.57 | US$ 537,057 | - | 3.2727 - 76.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:15:35 | 10 | US$ 3.54 | USD |
Aditxt Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.55M | 441.85k | - | 934k | -27.65M | -62.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aditxt News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/01/2023 | 15:39 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/16/2023 | 15:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/15/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 11/13/2023 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/13/2023 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/13/2023 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/13/2023 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/09/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/07/2023 | 16:20 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 10/11/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/06/2023 | 07:00 | GlobeNewswire Inc. | Aditxt, Inc. to Present at 8th Annual Dawson James.. |
| 10/05/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.51 | 5.30 | 3.30 | 3.91 | 1,741,881 | 0.00 | 0.0% |
| 1 Month | 5.90 | 7.00 | 3.2727 | 4.03 | 565,626 | -2.39 | -40.51% |
| 3 Months | 22.44 | 27.82 | 3.2727 | 6.51 | 248,658 | -18.93 | -84.36% |
| 6 Months | 25.20 | 68.08 | 3.2727 | 16.05 | 338,988 | -21.69 | -86.07% |
| 1 Year | 68.80 | 76.40 | 3.2727 | 29.61 | 397,280 | -65.29 | -94.9% |
| 3 Years | 80.00 | 1,139.60 | 3.2727 | 64.04 | 2,477,669 | -76.49 | -95.61% |
| 5 Years | 211.20 | 1,139.60 | 3.2727 | 75.69 | 2,350,905 | -207.69 | -98.34% |
Aditxt Description
| Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. |
